Darunavir en pacientes naïve: estudio ARTEMISVicente Estrada(Instituto de Salud Carlos III), Mónica Fuster(Hospital Clínico San Carlos)Enfermedades Infecciosas y Microbiología ClínicaOctober 1, 200810.1016/s0213-005x(08)76548-0Cited by 8SaveCiteExport RISWatch citationsRelated PapersSexual Activity Without Condoms and Risk of HIV Transmission in Serodifferent Couples When the HIV-Positive Partner Is Using Suppressive Antiretroviral Therapy|JAMA|2016|1.4kRisk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study|The Lancet|2019|1kAssociation Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19|JAMA|2021|728The KLEAN study of fosamprenavir-ritonavir versus lopinavir-ritonavir, each in combination with abacavir-lamivudine, for initial treatment of HIV infection over 48 weeks: a randomised non-inferiority trial|The Lancet|2006|343Altered metabolism of gut microbiota contributes to chronic immune activation in HIV-infected individuals|Mucosal Immunology|2014|332